Cargando…

Usp18 Expression in CD169(+) Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV

Ebola virus epidemics can be effectively limited by the VSV-EBOV vaccine (Ervebo) due to its rapid protection abilities; however, side effects prevent the broad use of VSV-EBOV as vaccine. Mechanisms explaining the efficient immune activation after single injection with the VSV-EBOV vaccine remain m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedrich, Sarah-Kim, Schmitz, Rosa, Bergerhausen, Michael, Lang, Judith, Cham, Lamin B., Duhan, Vikas, Häussinger, Dieter, Hardt, Cornelia, Addo, Marylyn, Prinz, Marco, Asano, Kenichi, Lang, Philipp Alexander, Lang, Karl Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157200/ https://www.ncbi.nlm.nih.gov/pubmed/32210083 http://dx.doi.org/10.3390/vaccines8010142

Ejemplares similares

Replication of Influenza A Virus in Secondary Lymphatic Tissue Contributes to Innate Immune Activation
por: Friedrich, Sarah-Kim, et al.
Publicado: (2021)

TLR7 Controls VSV Replication in CD169(+) SCS Macrophages and Associated Viral Neuroinvasion
por: Solmaz, Gülhas, et al.
Publicado: (2019)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

Map3k14 as a Regulator of Innate and Adaptive Immune Response during Acute Viral Infection
por: Hamdan, Thamer A., et al.
Publicado: (2020)

CD169(+) macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection
por: Shaabani, Namir, et al.
Publicado: (2016)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
por: Pinski, Amanda N., et al.
Publicado: (2020)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs
por: Cao, Wenguang, et al.
Publicado: (2023)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
por: Cham, Lamin B., et al.
Publicado: (2019)

Multiple functions of USP18
por: Honke, Nadine, et al.
Publicado: (2016)

Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression
por: Bhat, Hilal, et al.
Publicado: (2020)

Integrin Alpha E (CD103) Limits Virus-Induced IFN-I Production in Conventional Dendritic Cells
por: Duhan, Vikas, et al.
Publicado: (2021)

NK cell–intrinsic FcεRIγ limits CD8(+) T-cell expansion and thereby turns an acute into a chronic viral infection
por: Duhan, Vikas, et al.
Publicado: (2019)

Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model
por: Lee, Ha-Na, et al.
Publicado: (2021)

Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral control
por: Duhan, Vikas, et al.
Publicado: (2016)

Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins
por: Lay Mendoza, Maria Fernanda, et al.
Publicado: (2020)

Ebola virus (EBOV) infection: Therapeutic strategies
por: De Clercq, Erik
Publicado: (2015)

B Cell‐Mediated Maintenance of Cluster of Differentiation 169–Positive Cells Is Critical for Liver Regeneration
por: Behnke, Kristina, et al.
Publicado: (2018)

Phylogenetic Analysis of Guinea 2014 EBOV Ebolavirus Outbreak
por: Dudas, Gytis, et al.
Publicado: (2014)

Usp18 Driven Enforced Viral Replication in Dendritic Cells Contributes to Break of Immunological Tolerance in Autoimmune Diabetes
por: Honke, Nadine, et al.
Publicado: (2013)

CD47 as a Potential Target to Therapy for Infectious Diseases
por: Cham, Lamin B., et al.
Publicado: (2020)

USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2
por: Warsi, Jamshed, et al.
Publicado: (2015)

Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs
por: Reynard, Olivier, et al.
Publicado: (2016)

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization()
por: Dahlke, Christine, et al.
Publicado: (2017)

Immune functions during chronic viral infections
por: Lang, Philipp, et al.
Publicado: (2014)

CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production
por: Khairnar, Vishal, et al.
Publicado: (2015)

Clock Rooting Further Demonstrates that Guinea 2014 EBOV is a Member of the Zaïre Lineage
por: Calvignac-Spencer, Sébastien, et al.
Publicado: (2014)

Estimating the Reproduction Number of Ebola Virus (EBOV) During the 2014 Outbreak in West Africa
por: Althaus, Christian L.
Publicado: (2014)

Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak
por: Olabode, Abayomi S., et al.
Publicado: (2015)

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
por: Rechtien, Anne, et al.
Publicado: (2017)

Tumor Necrosis Factor-Mediated Survival of CD169(+) Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection
por: Shinde, Prashant V., et al.
Publicado: (2018)

Systematic Genome-wide Screening and Prediction of microRNAs in EBOV During the 2014 Ebolavirus Outbreak
por: Teng, Yue, et al.
Publicado: (2015)

Development and Evaluation of a Rapid and Sensitive EBOV-RPA Test for Rapid Diagnosis of Ebola Virus Disease
por: Yang, Mingjuan, et al.
Publicado: (2016)

Development of an EBOV MiniG plus system as an advanced tool for anti-Ebola virus drug screening
por: Hsu, Chi-Ju, et al.
Publicado: (2023)

Family-Wide Survey of miR169s and NF-YAs and Their Expression Profiles Response to Abiotic Stress in Maize Roots
por: Luan, Mingda, et al.
Publicado: (2014)

Enforced viral replication, a mechanism for immune activation
por: Lang, Karl S, et al.
Publicado: (2014)

The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1
por: Alsamman, Alsamman M., et al.
Publicado: (2020)

Identification of promising anti-EBOV inhibitors: de novo drug design, molecular docking and molecular dynamics studies
por: Mohamed, Eslam A. R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eucohoaf07v4k5okgqolm0ogmp